Catalyst
Pit
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
Terminal
Pit Consensus
Insiders
Politicians
Institutions
News
Screener
More ▾
☰
CMPX
Compass Therapeutics, Inc.
NASDAQ · Biological Products, (No Diagnostic Substances)
Last close
$1.04
· 2026-09-30
ABOUT
Exchange
NASDAQ
Sector
Healthcare
Industry
Biological Products, (No Diagnostic Substances)
Market cap
$187.29M
RECENT INSIDER TRADES
2026-10-02
· Lerner Neil
(Chief Accounting Officer)
· BUY
2026-09-25
· Lerner Neil
(Chief Accounting Officer)
· BUY
2025-05-27
· Schuetz Thomas J.
(CHIEF EXECUTIVE OFFICER)
· BUY
2025-04-11
· GORDON CARL L
(Director)
· SELL
2025-04-11
· ORBIMED ADVISORS LLC
(Director)
· SELL
INSTITUTIONAL OWNERSHIP
Institutional holders
224
Shares held
180,754,203
Value
$410.47M
Percent of shares outstanding
100.37%
As of quarter end
2026-06-30
RECENT NEWS
Compass Therapeutics CAO Neil Lerner buys $2,849 in CMPX shares
Wedbush downgrades Compass Therapeutics; FDA seeks additional trial
Compass Therapeutics: A Promising, But Shrinking, Window Of Opportunity
Wedbush downgrades Compass Therapeutics on FDA trial concerns
Stifel maintains Compass Therapeutics price target at $6
Catalyst
Pit
Features
Coming soon
Pricing
Coming soon
Privacy
Terms
Disclaimer
Affiliate Terms
Contact
2026 CATALYSTPIT · NOT FINANCIAL ADVICE · DELAYED FILINGS